XML 62 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets and Goodwill (Tables)
3 Months Ended
Mar. 31, 2012
Intangible Assets and Goodwill  
Schedule of intangible assets by category

 

 

 

 

Gross

 

 

 

Intangible

 

Weighted

 

 

 

Carrying

 

Accumulated

 

Assets,

 

Average

 

March 31, 2012

 

Value

 

Amortization

 

Net

 

Life (Years)

 

 

 

 

 

 

 

 

 

 

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

Acquired developed product rights

 

 $

2,186,000

 

 $

(700,207)

 

 $

1,485,793

 

11.9

 

Technology

 

359,334

 

(6,201)

 

353,133

 

7.0

 

Licenses

 

64,250

 

(7,067)

 

57,183

 

16.8

 

Other

 

40,615

 

(11,242)

 

29,373

 

8.8

 

 

 

2,650,199

 

(724,717)

 

1,925,482

 

11.2

 

 

 

 

 

 

 

 

 

 

 

Non-amortized intangible assets:

 

 

 

 

 

 

 

 

 

Acquired IPR&D product rights

 

1,413,748

 

-  

 

1,413,748

 

 

 

 

 

 

 

 

 

 

 

 

 

Total intangible assets

 

 $

4,063,947

 

 $

(724,717)

 

 $

3,339,230

 

 

 

 

 

 

 

Gross

 

 

 

Intangible

 

Weighted

 

 

 

Carrying

 

Accumulated

 

Assets,

 

Average

 

December 31, 2011

 

Value

 

Amortization

 

Net

 

Life (Years)

 

 

 

 

 

 

 

 

 

 

 

Amortizable intangible assets:

 

 

 

 

 

 

 

 

 

Acquired developed product rights

 

  $

2,186,000

 

  $

(666,142)

 

  $

1,519,858

 

11.9

 

Technology

 

 

2,534

 

 

(190)

 

2,344

 

10.0

 

Licenses

 

64,250

 

(6,108)

 

58,142

 

16.8

 

Other

 

40,600

 

(10,246)

 

30,354

 

8.8

 

 

 

2,293,384

 

(682,686)

 

1,610,698

 

11.9

 

 

 

 

 

 

 

 

 

 

 

Non-amortized intangible assets:

 

 

 

 

 

 

 

 

 

Acquired IPR&D product rights

 

1,234,000

 

-  

 

1,234,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Total intangible assets

 

  $

3,527,384

 

  $

(682,686)

 

  $

2,844,698

Schedule of changes in carrying value of goodwill

 

 

Balance at December 31, 2011

 

$

1,887,220

 

Acquisition of Avila

 

 

145,078

 

Tax benefit on the exercise of Pharmion converted stock options

 

(422)

 

Balance at March 31, 2012

 

$

2,031,876